41 results
8-K
EX-99.1
NEO
Neogenomics Inc.
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
and the Company presented new data in early breast cancer at the European Society for Medical Oncology (ESMO) Congress, highlighting RaDaRâ„¢ as a highly
8-K
EX-99.1
btipzug
10 Aug 21
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
u5ivpi5u35yz4cmknev
28 Apr 20
NeoGenomics Reports 11% Revenue Growth to $106 Million
8:15am
8-K
EX-10.1
grsrd2
2 Dec 19
Departure of Directors or Certain Officers
5:07pm
424B5
uzmchh 9h
10 Aug 18
Prospectus supplement for primary offering
10:09am
424B5
0uj k0i617u
6 Aug 18
Prospectus supplement for primary offering
4:59pm
8-K
EX-99.2
6muydsi t7
6 Aug 18
NeoGenomics Announces Proposed Public Offering of Common Stock
4:42pm
8-K
EX-99.1
29b3iwqi1b 5b
25 May 18
Regulation FD Disclosure
5:06pm